Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc. scores highest on Nitro (92) and lowest on Price (0). Its PosiPenta is 46.84 out of 100, around the middle of similar companies.
On the Penta Grid this week, Xeris Biopharma Holdings, Inc. is Grid #343 of 837 in the Healthcare sector in United States, and Grid #2,234 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Xeris Biopharma Holdings, Inc. | 46.84 | 0 | 85 | 92 | 1 | 56 |
| BioCryst Pharmaceuticals, Inc. | 56.90 | 0 | 65 | 65 | 98 | 56 |
| GeneDx Holdings Corp. | 38.32 | 9 | 53 | 42 | 40 | 49 |
| LeMaitre Vascular, Inc. | 57.12 | 37 | 59 | 52 | 60 | 78 |
| Braveheart Bio, Inc. | 46.99 | 0 | 39 | 45 | 79 | 72 |
| Xencor, Inc. | 43.38 | 20 | 21 | 78 | 48 | 51 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -103.10 |
| P/B ratio | -193.11 |
EEarnings
| Trailing EPS | ₹-9.47 |
| Forward EPS | ₹35.04 |
NNitro
| Price | 976.51 |
| 52-week high | 1073.12 |
| 52-week low | 497.25 |
| Fall from 52-week high | 9.0% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 18.85 |
AAnchor
| Beta (price swings) | 0.84 |
| Market cap | ₹17,803 Cr |
| Insider holding | 3.03% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Xeris Biopharma Holdings, Inc.'s PosiPenta score?
Xeris Biopharma Holdings, Inc.'s PosiPenta is 46.84 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Xeris Biopharma Holdings, Inc. stand on the Penta Grid?
On the Penta Grid this week, Xeris Biopharma Holdings, Inc. is Grid #343 of 837 in the Healthcare sector in United States, and Grid #2,234 of 4,000 in United States.
Which PosiPenta pillar is strongest for Xeris Biopharma Holdings, Inc.?
Nitro (momentum), with a score of 92 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Xeris Biopharma Holdings, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has Xeris Biopharma Holdings, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.80 points, from 44.04 to 46.84.
PositoAI is for research and education only and is not investment advice.